What You Should Know
Los Angeles-based health system Cedars-Sinai has deployed OpenEvidence systemwide, giving its entire enterprise care team access to an AI-enabled clinical reference tool directly integrated within the Electronic Health Record (EHR).The AI platform functions at the point of care by dynamically linking the latest peer-reviewed medical literature and scientific findings with an individual patient’s unique history, including comorbidities, prior procedures, medications,
Read More
Surescripts Expands Prior Authorization Automation: Slashing Prescription Approval Times as New CMS Interoperability Rules Loom
What You Should Know
Surescripts has expanded its Prior Authorization Automation solution, increasing the number of enabled clinicians by 50% since December 2025 to reach 68,000 prescribers across 42 major health systems.Automated prior authorization systems achieved a median approval time of just 18 seconds when clinical determination criteria were met, bypassing traditional manual forms, faxes, and telephone calls.Real-Time Prescription Benefit tools saved patients $19.7 million from
Read More
Nourish Raises $100M to Expand Nation’s Largest Dietitian-Led Virtual Clinic
What You Should Know
Nourish—the country’s largest dietitian-led virtual metabolic clinic—disclosed a $100M Series C funding round led by Menlo Ventures, accelerating its total capital raised to $215M. The round included participation from Thrive Capital, Index Ventures, J.P. Morgan Growth Equity Partners, Maverick Ventures, Y Combinator, BoxGroup, Atomico, Daybreak and Operator Partners. The platform addresses nutrition-related chronic conditions by delivering clinical outcomes that
Read More
Commure Secures $70M to Drive 85% Autonomous Revenue Cycle Execution
What You Should Know
Commure, an AI platform for healthcare operations, secured a $70M financing round at a $7 billion post-money valuation led by General Catalyst, with participation from Sequoia Capital, Morgan Stanley, and Kirkland & Ellis.Tackling the $1 Trillion Problem: The company’s agentic AI infrastructure targets administrative waste—a sector that consumes an estimated $1 trillion annually in the U.S. alone.Proven Operational Automation: Commure’s end-to-end revenue cycle
Read More
Century Health Raises $5M for CHARM AI Platform to Accelerate Life Sciences Research
What You Should Know
Century Health has closed an oversubscribed $5M seed financing round led by Origin Ventures, bringing its total funding to an industry-accelerated position.The platform's proprietary Century Health Abstraction & Retrieval Model (CHARM) automates the curation of unstructured EHR data (notes, reports, and documentation), achieving a 97% accuracy rate validated against clinical expert judgment.Century Health expanded its specialty provider data network 60x over the past
Read More
Reimagining Medical Devices in the AI Era: The 3 Structural Shifts Driving Venture-Scale Growth
What You Should Know:
In their newly released whitepaper, Medical Devices in the AI Era, Aegis Ventures outlines how the medical device sector has historically underperformed in venture portfolios, remaining completely flat at just 2% to 3% of overall healthcare venture capital since 2018, despite representing a $200 billion annual market.The Software Evolution: The axis of competition is moving from physical hardware ("atoms") to intelligent software ("algorithms"), opening the door to
Read More
M&A: Qualtrics Completes $6.75B Acquisition of Press Ganey Forsta
What You Should Know
Qualtrics has officially completed its acquisition of healthcare experience leader Press Ganey Forsta for $6.75B, marking the largest technology acquisition in Utah history.Category Expansion: The deal fuses Qualtrics’ experience management (XM) AI and data platform with Press Ganey Forsta's massive clinical, operational, and regulatory benchmarking footprint.The "Experience Gap" Mandate: Driven by consumer expectations permanently altered by AI, modern patients no longer
Read More
Viz.ai Launches Viz Pulmonary™ Suite: AI-Powered Workflows for COPD, Lung Nodules, and PE
What You Should Know
Viz.ai has introduced the Viz Pulmonary™ Suite, an integrated AI solution designed to manage acute and chronic pulmonary conditions in a single platform.The suite targets three major pulmonary challenges: Chronic Obstructive Pulmonary Disease (COPD), lung nodules, and pulmonary embolism (PE).Clinical Impact: In a single-center study, the integrated Viz PE tool reduced time to treatment from 1.75 days to 0.56 days and lowered in-hospital mortality among high-risk
Read More
FDA Grants 510(k) Clearance for Glooko’s EndoTool IV Cloud Insulin Dosing Platform
What You Should Know
Glooko has received U.S. FDA 510(k) clearance for EndoTool IV Cloud, making it the first cloud-based, patient-specific insulin dosing platform cleared for hospital use.The system is the cloud-native evolution of EndoTool IV, a clinical decision support solution used to manage intravenous (IV) insulin therapy for hospitalized patients.The cloud architecture is designed to reduce on-premise infrastructure requirements, streamline maintenance, and support centralized updates
Read More
Innovaccer 2026 Payer AI Report: Nearly 80% of Insurers to Buy or Co-Develop AI Capabilities
What You Should Know
Nearly 80% of health plan executives now plan to buy or co-develop AI capabilities with vendors, a sharp reversal from late 2024 when 78% were attempting to build internally, according to a new report from Innovaccer. Financial Commitment: Approximately 75% of payers intend to spend over $10 million on AI-driven payment and care outcome initiatives over the next 3–5 years.Operational Reality: Despite high ambitions, 86% of payers admit they are not fully ready to
Read More
